Cardiovascular disease prevention in people living with HIV: from REPRIEVE to a <i>statin</i> of grace-Reference-Cited by-同舟云学术

Cardiovascular disease prevention in people living with HIV: from REPRIEVE to a statin of grace

Published:2023-09-07 Issue:41 Volume:44 Page:4308-4309
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Vergallo Rocco¹²^ORCID,Patrono Carlo³^ORCID

Affiliation:

1. Interventional Cardiology Unit, Cardiothoracic and Vascular Department (DICATOV), Department of Internal Medicine and Medical Specialties (DIMI), IRCCS Ospedale Policlinico San Martino, Università di Genova , Viale Benedetto XV, 6, 16132 Genova , Italy

2. Department of Internal Medicine and Medical Specialties (DiMI), Università di Genova , Viale Benedetto XV, 6, 16132 Genoa , Italy

3. Department of Pharmacology, Catholic University of the Sacred Heart , Rome , Italy

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/eurheartj/article-pdf/44/41/4308/52692260/ehad594.pdf

Reference12 articles.

1. Pitavastatin to prevent cardiovascular disease in HIV infection;Grinspoon;N Engl J Med,2023

2. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Goff;J Am Coll Cardiol,2014

3. Cause-specific mortality in HIV-positive patients who survived ten years after starting antiretroviral therapy;Trickey;PLoS One,2016

4. HIV infection and cardiovascular disease;Hemkens;Eur Heart J,2014

5. Recommendations for managing drug-drug interactions with statins and HIV medications;Wiggins;Am J Cardiovasc Drugs,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of statins beyond lipid-lowering agents in ART-treated HIV infection;Frontiers in Immunology;2024-04-09